author

 
 

Meta

Lisa Jarvis
Japan Times
COMMENTARY / World
Jan 11, 2023
Don't write off the retooled COVID-19 boosters
Two new studies claim the bivalent omicron shot is no better than the original vaccine. But there are important caveats.
Japan Times
COMMENTARY / World
Jan 4, 2023
Cancer vaccine hunt finally makes progress
A small study shows promise in deploying mRNA technology against melanoma — but fighting tumors is vastly more complex than tackling COVID-19.
Japan Times
COMMENTARY / World
Dec 21, 2022
Another Crispr first: New treatment wipes out teen's cancer
Next-generation Crispr gene-editing was used to create a therapy that attacked a 13-year-old's stubborn leukemia.
Japan Times
COMMENTARY / World
Dec 2, 2022
Amgen has a contender in the weight-loss drug wars
Amgen's obesity drug offers a new twist on proven methods to help people lose unwanted pounds.
Japan Times
COMMENTARY / World
Nov 21, 2022
Pfizer’s RSV vaccine succeeds where others failed
Early data bodes well for Pfizer's RSV shot, which would be given during pregnancy to protect infants in the early months of life.
Japan Times
COMMENTARY / World
Nov 16, 2022
New weight-loss drugs work, but who's paying?
Novo Nordisk and Eli Lilly say they can treat obesity with a weekly injection. But insurers aren't yet on board.
Japan Times
COMMENTARY
Oct 24, 2022
New COVID-19 variants have arrived. How worried should you be?
Fearmongering headlines on the new COVID-19 variants are misleading and counter the message on the effectiveness of vaccines.
Japan Times
COMMENTARY / World
Oct 12, 2022
Don’t cancel your colonoscopy just yet
Data from a large trial on colonoscopies appears to cast doubt over the benefits of the colon cancer screen. But it's a lot more complicated.
Japan Times
COMMENTARY / World
Oct 4, 2022
New Alzheimer's drug from Biogen and Eisai is just the beginning
A successful late-stage trial of lecanemab gives researchers promising new avenues for tackling this hard-to-beat disease.
Japan Times
COMMENTARY / World
Sep 1, 2022
To fight monkeypox and other viruses, look harder in the sewers
Health authorities rely on a patchwork system for testing wastewater, often missing important information about virus outbreaks such as monkeypox.
Japan Times
COMMENTARY / World
Jun 8, 2022
The drug that could transform breast cancer treatment
The early success of Enhertu, from AstraZeneca and Daiichi Sankyo, bodes well for an entire class of medicines that may one day replace conventional chemotherapy.
Japan Times
COMMENTARY / World
Jun 5, 2022
Omicron is turning out to be a weak vaccine
Unvaccinated people who got COVID-19 last winter have little protection from reinfection, and even vaccinated people might be vulnerable after only a few months.
Japan Times
COMMENTARY / World
May 25, 2022
Monkeypox isn’t looking like a COVID-sized threat
It's still early, but contact-tracing efforts and analysis of the virus's genome offer hope that this outbreak can be contained.
Japan Times
COMMENTARY / World
Apr 8, 2022
Confronting AI’s potential to create new chemical weapons
Although the immediate danger seems minimal, efforts are needed to safeguard machine-learning models used in chemical and drug discovery.
Japan Times
COMMENTARY / World
Mar 9, 2022
Crispr might actually live up to its immense hype
The Nobel prize-winning technology is moving from a concept to the clinic at a breathtaking pace.

Longform

Visitors walk past Sou Fujimoto's Grand Ring, which has been recognized as the largest wooden structure in the world.
Can a World Expo still matter? Japan is about to find out.